Revenue (Tables)

3 Months Ended

Mar. 31, 2019

Disaggregation of Revenue [Abstract]

Disaggregation of Revenue [Table Text Block]

The following tables disaggregate our revenue from contracts with customers by business and geographic region (in millions):

	Three Months Ended March 31,
Businesses	2019		2018
Endoscopy
U.S.	$	253	$	231
International	187		187
Worldwide	440		418
Urology and Pelvic Health
U.S.	231		197
International	94		96
Worldwide	326		293
Cardiac Rhythm Management
U.S.	288		290
International	203		203
Worldwide	491		493
Electrophysiology
U.S.	36		35
International	43		39
Worldwide	79		75
Neuromodulation
U.S.	144		131
International	42		38
Worldwide	186		169
Interventional Cardiology
U.S.	296		281
International	365		364
Worldwide	661		645
Peripheral Interventions
U.S.	156		145
International	155		142
Worldwide	311		288
Total Company
U.S.	1,403		1,310
International	1,090		1,069
Net Sales	$	2,493	$	2,379

	Three Months Ended March 31,
Geographic Regions	2019		2018
U.S.	$	1,403	$	1,310
EMEA (Europe, Middle East and Africa)	561		563
APAC (Asia-Pacific)	437		415
Latin America and Canada	92		91
	$	2,493	$	2,379
Emerging Markets†	$	297	$	262

^†We define Emerging Markets as the